NextCure, Inc.NXTCNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank38
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-49.61M
↓ 31% vs avg
Percentile
P38
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-37.74M
Historical baseline
PeriodValueYoY Change
TTM$-49.61M-21.6%
2024$-40.80M+23.0%
2023$-52.97M+1.7%
2022$-53.89M+5.9%
2021$-57.24M-27.3%
2020$-44.95M-26.2%
2019$-35.62M-545.7%
2018$7.99M+163.9%
2017$-12.51M-